Skip to main content

New England Journal of Medicine Archives

New lab formulary improves quality, cuts cost

Sep. 21, 2017—An effort at Vanderbilt University Medical Center (VUMC) to enhance clinical decision making through cross-departmental collaboration and effective use of diagnostics has improved patient care and saved the institution more than $1 million in 2016, VUMC officials reported this week.

Read more

Reporter


New approach for staph-related skin abscesses explored

Jul. 13, 2017—New multicenter research that includes Vanderbilt University Medical Center (VUMC) investigators, could change treatment approaches to simple skin abscesses, infections often caused by Staphylococcus aureus (staph) bacteria.

Read more

Health and Medicine Reporter Research


Preserving NIH’s Fogarty International Center crucial for global health efforts

May. 26, 2017—This week Douglas Heimburger, M.D., M.S., professor of Medicine at Vanderbilt, joined a growing chorus calling for preservation of the Fogarty International Center of the National Institutes of Health (NIH).

Read more

Health and Medicine Reporter Research Research Blog


Social risk factors influence outcomes, Medicare payment

Feb. 8, 2017—Social risk factors including income, education and ethnic background influence health outcomes and should be taken into account in Medicare payment models, according to a New England Journal of Medicine “Perspective” titled “Social Risk Factors and Equity in Medicare Payment.”

Read more

Health and Medicine Reporter Research


Study finds smaller insurers earning profits in new market

Feb. 2, 2017—The researchers examine whether the financial struggles of some major insurers under the Affordable Care Act reflect a policy failure or a mismatch of these firms’ capabilities and strategies to a newly created market.

Read more

Law, Business and Politics Reporter Research


Automation speeds clinical safety surveillance: study

Jan. 26, 2017—Using patient outcomes data from approximately 1,800 hospitals, the largest demonstration to date of automated safety surveillance of a medical device is reported in this week’s New England Journal of Medicine.

Read more

Reporter


Study details rare heart risk of certain cancer therapies

Nov. 3, 2016—Combination therapy using two approved immunotherapy drugs for cancer treatment may cause rare and sometimes fatal cardiac side effects linked to an unexpected immune response. In a study led by Vanderbilt University Medical Center (VUMC) investigators and published in the Nov. 3 issue of the New England Journal of Medicine, researchers describe two cases of...

Read more

Reporter


Emerging field of cardio-oncology seeks better tools

Oct. 27, 2016—Improved therapies have led to a spike in the number of people living with cancer, and today there are more than 15.5 million survivors in the United States. However, some of these therapies can cause toxicities to the heart, the vessels and the body’s metabolism.

Read more

Reporter


New rules for science researchers would mark an overdue ethics update

Sep. 16, 2016—New ethical rules for scientists who do experiments involving human beings are about to kick in. It's the first update in more than 40 years.

Read more

Health and Medicine myVU myVU News


Reduced-nicotine cigarettes decreased dependence and frequency of smoking: NEJM study

Sep. 30, 2015—Reduced-nicotine cigarettes were beneficial in reducing nicotine exposure and dependence, and also the number of cigarettes smoked per day, when compared with standard-nicotine cigarettes in a six-week study published in the New England Journal of Medicine.

Read more

Health and Medicine Reporter Research


New type of trial shows promise for several cancers

Aug. 20, 2015—Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation.

Read more

Health and Medicine Reporter Research


New targeted therapy shows promise for rare joint tumor

Aug. 6, 2015—Vanderbilt-Ingram Cancer Center (VICC) investigators and colleagues at several major medical centers have been testing a new targeted therapy that is showing promise for the treatment of a rare tumor that forms in and around joint cavities.

Read more

Health and Medicine Healthcare Solutions Reporter Research Strategic Plan


Page 1 of 212